Intellia Therapeutics (NTLA) AGM 2026 summary

Opening remarks and agenda

• Chairperson welcomed attendees and introduced board members and executive team, including key officers and the independent auditor.

• Meeting agenda included formal business as set forth in the Notice of Annual Meeting and Proxy Statement.

Board and executive committee updates

• Board members and executive officers present were introduced, including roles such as CEO, CFO, CTO, and General Counsel.

• Inspector of Election and independent auditor were identified and their roles explained.

Shareholder proposals

• Three proposals were presented: election of three Class I directors, ratification of the independent auditor, and advisory approval of executive compensation.